CYH Community Health Systems, Inc. Common Stock
NYSE · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Jul 23, 2026CYH Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
CYH Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
| Ex-Datum | Split | Typ |
|---|---|---|
| 22. April 2016 | 121-for-100 | Vorwärts |
Über Community Health Systems, Inc. Common Stock Unternehmensübersicht von Wikipedia
Community Health Systems, Inc. (CHS) is a Fortune 500 company based in Franklin, Tennessee. It was the largest provider of general hospital healthcare services in the United States in terms of number of acute care facilities. In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
In August 2015, the company announced plans to spin off 38 hospitals and its management and consulting subsidiary, Quorum Health Resources, into a new publicly traded company called Quorum Health Corporation. The company completed the spinoff of Quorum Health Corporation on April 29, 2016. Quorum owns or leases hospitals across 16 states, primarily in cities or counties with populations of 50,000 or less. In April 2020 Quorum declared bankruptcy and is no longer trading on the NYSE.
On October 3, 2016, CHS was removed from the S&P Midcap 400 and added to the S&P Smallcap 600. Under CEO Wayne T. Smith, the company's stock has lost over 76% of its value since the year 2000.
Chinese billionaire Tianqiao Chen had a 22.2 percent stake in Community Health Systems in 2017.
History
Founding and early years (1985–2014)
E. Thomas Chaney, former executive of Hospital Affiliates, Inc. and David Steffy and Richard Ragsdale, former executives at Hospital Corporation of America spinoff Republic Health Corporation, formed Community Health Systems in 1985.
The company made its initial public offering in 1991. In 1996, the company was purchased by private equity firm Forstmann Little & Company. Community Health Systems went public again in 2000. In August 2003, the company acquired Southside Regional Medical Center. On October 10, 2015, the 372-bed Grandview Medical Center began operating in Birmingham, Alabama, replacing Trinity Medical Center.
In 2000, Community Health Systems paid $31 million to the United States Department of Justice to settle a review of its billing practices.
In 2007, Community Health Systems purchased Plano, Texas-based Triad Hospitals for $6.8 billion, adding nearly 50 hospitals, hospital management and consulting business Quorum Health Resources, and nearly doubling the size of the company. Among the facilities included in the deal was McKenzie-Willamette Hospital in Springfield, Oregon; Trinity Medical Center in Birmingham, Alabama; and the seven hospitals of Lutheran Health Network in the Ft. Wayne, Indiana region.
In 2010, McKenzie-Willamette's healthcare workers' union, SEIU, Local 49, claimed that workload increases, slashed benefits, and staff reductions had lowered the quality of both patient care and quality of life for employees. The union, in its "Profits Before Community" campaign against the hospital, continues to highlight that profits have tripled while charitable care and employee benefits have steadily decreased since the hospital moved from a non-profit to a for-profit enterprise under CHS.
In 2011, it was accused by Tenet Healthcare of overbilling Medicare in its aggressive admissions policy compared to its peers. It was subpoenaed by Medicare on its aggressive billing to the Medicare systems.
In 2013, Community Health Systems entered into an agreement with Health Management Associates to purchase HMA for about $3.6 billion in cash and stock. The merger was completed in January 2014 and made Community Health Systems the largest for-profit hospital operator at the time, with 206 hospitals in 29 states. The acquisition of HMA brought with it liability for lawsuits and criminal charges of fraudulent claims against Medicare and other federal programs. CHS settled these claims for $262 million in October, 2018.
On August 4, 2014, Community Health Systems paid $95.14 million to the United States Department of Justice to resolve multiple lawsuits "alleging that the company knowingly billed government health care programs for inpatient services that should have been billed as outpatient or observation services". As part of the agreement, Community Health Systems was required to enter into a corporate integrity agreement that required the company to participate in compliance efforts.
It was reported on August 18, 2014, that hackers broke into Community Health System's records system and stole data on 4.5 million patients. These data included names, Social Security numbers, physical addresses, birthdays and telephone numbers. CHS provided all patients whose records were impacted with free identity theft protection.
Recent developments (2015–present)
On February 2, 2015, Community Health Systems was required to pay $75 million to settle allegations "that they made illegal donations to county governments to reap more federal dollars under a now-discontinued matching program". The allegations were brought about by a former CHS employee in a complaint under the False Claims Act.
In October 2015, Community Health Systems paid $13 million to the United States Department of Justice to resolve allegations related to the False Claims Act.
After CHS agreed in 2015 to sell Memorial Hospital of Salem County in New Jersey to Prime Healthcare Foundation, a nonprofit affiliated with Prime Healthcare Services; the sale was approved by New Jersey in early February 2017.
On December 6, 2016, a former CFO of a CHS hospital was awarded $1.9 million in a whistleblower lawsuit he filed after he was terminated for refusing to submit false financial documents.
In January 2017, a settlement between investors and CHS executives for $60 million was reached. The settlement resolved allegations of "breach of fiduciary duty" by CHS executives.
In March 2017, Quorum's board retained outside counsel in relation to whether Community Health Systems had committed fraud with regards to financial projections for Quorum, and whether any of its current management may have been involved in any possible fraud. In June 2017 Quorum said although the investigation did not produce "conclusive evidence" of fraud the projections appeared to be incompetent at best.
In April–July 2017, Community Health Systems rejected overtures from key Lutheran Health Network doctors to facilitate sale of its profitable network in CHS to a third party, after assertions of continual lack of re-investment into the network's facilities and staff by CHS management. After those discussions/accusations became public, several key leaders of the affiliated hospitals, Lutheran and Dupont, and the network were fired or resigned. Key prominent local community leaders Chuck Surack and Tom Kelley resigned from the Lutheran Health Network's and hospitals' advisory boards.
On March 13, 2018, it was reported that the company had hired financial advisory firm Lazard to help address long-term debt.
On August 1, 2018, CHS completed the sale of 425-bed Munroe Regional Medical Center in Ocala, Fla., to Altamonte Springs, Fla.-based Adventist Health System.
On May 22, 2019, AdventHealth announced they had signed definitive agreements to purchase 193-bed Heart of Florida Regional Medical Center in Davenport, Florida, and 160-bed Lake Wales Medical Center in Lake Wales, Florida, from affiliates of CHS.
In December 2019, CHS announced that subsidiaries of the company have completed the sale of three Virginia hospitals – Southside Regional Medical Center in Petersburg, Southampton Memorial Hospital in Franklin, and Southern Virginia Regional Medical Center in Emporia, effective on January 1, 2020.
On April 27, 2020, CHS announced that an affiliate of the company has signed a definitive agreement to sell its majority ownership interest in 84‑bed St. Cloud Regional Medical Center and its associated healthcare operations in St. Cloud, Florida, to a subsidiary of Orlando Health. Orlando Health currently holds minority ownership interest in St. Cloud and will purchase the remaining interest through this transaction.
On September 30, 2020, CHS announced that an affiliate of the company has completed the sale of 480-bed Bayfront Health St. Petersburg and its associated assets to a subsidiary of Orlando Health.
In its annual Form 10-K filed in 2019, it identified Florida, Texas and Indiana as areas of geographic concentration.
In 2014, CHS had around 200 hospitals, but the number had declined to around 85 in 2021.
From March 2020 to May 2021, during the COVID-19 pandemic, CHS filed more than 19,000 lawsuits against individuals for not being able to pay off their medical debt (some from hospitals it no longer owned) even as the company collected over $700 million in Covid relief funds from the federal government. Many of these lawsuits were against people who could not pay the legal fees to challenge CHS in court. (Due to the fact that these are civil suits and not criminal suits, the defendants do not receive a state-appointed lawyer.) In 2020, CHS posted its most profitable year in at least a decade.
Predatory liens practices
Lawsuits have been filed against CHS hospitals for alleged predatory liens practices where hospitals file for liens rather than bill individuals' health insurers, resulting in massive fees for patients.
Quelle: Wikipedia (Englisch), CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | CYH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 1.55-Jahres-Durchschnitt ≈3.4 | ≈3.4 | 15.5 | Unterbewertet | |
| P/S (TTM) | 0.05-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 1.2 | Unterbewertet | |
| K/B (MRQ) | -0.35-Jahres-Durchschnitt ≈-0.5 | ≈-0.5 | · | · | |
| EV / EBITDA | 7.15-Jahres-Durchschnitt ≈13.1 | ≈13.1 | 10.6 | Unterbewertet | |
| Kurs / FCF (TTM) | -2.15-Jahres-Durchschnitt ≈-0.8 | ≈-0.8 | · | · | |
| Kurs / Cashflow (TTM) | 3.05-Jahres-Durchschnitt ≈-1.6 | ≈-1.6 | 6.5 | Unterbewertet | |
| EV / Revenue (EV / Umsatz) | 0.85-Jahres-Durchschnitt ≈1.0 | ≈1.0 | · | · | |
| EV / FCF | 50.55-Jahres-Durchschnitt ≈-4.9 | ≈-4.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | CYH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | 11.4%5-Jahres-Durchschnitt ≈8.4% | ≈8.4% | 13.8% | Im Einklang | |
| EBITDA Margin (EBITDA-Marge) | 11.9%5-Jahres-Durchschnitt ≈8.4% | ≈8.4% | 10.2% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 3.9%5-Jahres-Durchschnitt ≈2.4% | ≈2.4% | 6.4% | Im Einklang | |
| Nettogewinnmarge (TTM) | 2.1%5-Jahres-Durchschnitt ≈0.24% | ≈0.24% | 4.3% | Schwach | |
| ROA (TTM) | 2.0%5-Jahres-Durchschnitt ≈0.20% | ≈0.20% | 3.7% | Im Einklang | |
| ROE (TTM) | -16.7%5-Jahres-Durchschnitt ≈-1.7% | ≈-1.7% | 8.2% | Schwach | |
| ROIC | 15.5%5-Jahres-Durchschnitt ≈7.4% | ≈7.4% | 10.2% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | CYH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | -6.95-Jahres-Durchschnitt ≈-7.8 | ≈-7.8 | 0.3 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 1.55-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 1.5 | Im Einklang | |
| Quick Ratio | 1.15-Jahres-Durchschnitt ≈1.0 | ≈1.0 | 1.0 | Im Einklang | |
| Langfristige Schulden / Eigenkapital (MRQ) | -6.95-Jahres-Durchschnitt ≈-7.8 | ≈-7.8 | 0.3 | Geringe Verschuldung |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | CYH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -1.2%5-Jahres-Durchschnitt ≈1.2% | ≈1.2% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 0.74%5-Jahres-Durchschnitt ≈1.1% | ≈1.1% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 1.1% | · | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 120.8% | · | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | -3.0% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 122.8% | · | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | -0.08% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | CYH | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.95-Jahres-Durchschnitt ≈0.9 | ≈0.9 | 0.9 | Im Einklang | |
| Receivables Turnover (Forderungsumschlag) | 5.75-Jahres-Durchschnitt ≈5.9 | ≈5.9 | 8.9 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$283.8K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Dez 13, 2012 | $0,21 | USD | ≈0.84% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Jul 21, 2026 | $-0.19 | $-0.06 | -201.1% |
| 31. März 2026 | $-0.48 | $-0.10 | -387.3% | |
| 31. Dezember 2025 | $-0.01 | $-0.10 | 90.5% | |
| 30. September 2025 | $1.27 | $-0.25 | 610.5% | |
| 30. Juni 2025 | $-0.05 | $-0.11 | 52.6% | |
| 31. März 2025 | $-0.03 | $-0.08 | 62.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | |
| Cost of Revenue | $1.86B | $1.95B | $1.99B | $1.98B | $2.04B | $1.96B | $2.15B | $2.35B | $2.67B | $3.01B | |
| Operating Expenses | $11.00B | $12.09B | $11.53B | $11.39B | $10.97B | $10.66B | $12.56B | $13.95B | $17.23B | $19.30B | |
| Operating Income | $1.49B | $542M | $957M | $821M | $1.40B | $1.13B | $650M | $208M | $-1.88B | $-860M | |
| Interest Income | $2M | $3M | $2M | $2M | $3M | $3M | $3M | $7M | $11M | $14M | |
| Pretax Income | $724M | $-283M | $207M | $349M | $499M | $422M | $-430M | $-715M | $-2.83B | $-1.72B | |
| Income Tax | $48M | $79M | $191M | $170M | $131M | $-185M | $160M | $-11M | $-449M | $-104M | |
| Net Income | $509M | $-516M | $-133M | $46M | $230M | $511M | $-675M | $-788M | $-2.46B | $-1.72B | |
| EPS (Basic) | $3.81 | $-3.90 | $-1.02 | $0.35 | $1.82 | $4.43 | $-5.93 | $-6.99 | $-22.00 | $-15.54 | |
| EPS (Diluted) | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 | $4.39 | $-5.93 | $-6.99 | $-22.00 | $-15.54 | |
| Shares (Basic) | 133,564,227 | 132,101,768 | 130,445,677 | 128,808,387 | 126,754,852 | 115,491,022 | 113,739,046 | 112,728,274 | 111,769,821 | 110,730,971 | |
| Shares (Diluted) | 135,012,240 | 132,101,768 | 130,445,677 | 130,060,319 | 130,597,410 | 116,544,561 | 113,739,046 | 112,728,274 | 111,769,821 | 110,730,971 | |
| EBITDA | $1.49B | $542M | $957M | $821M | $1.40B | $1.13B | $1.26B | $908M | $-1.02B | $240M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $260M | $37M | $38M | $118M | $507M | $1.68B | $216M | $196M | $563M | $238M | |
| Receivables | $2.08B | $2.29B | $2.23B | $2.04B | $2.06B | $1.93B | $2.26B | $2.35B | $2.38B | $3.18B | |
| Other Current Assets | $381M | $358M | $275M | $235M | $269M | $338M | $358M | $400M | $462M | $568M | |
| Current Assets | $3.23B | $3.30B | $3.21B | $3.08B | $3.48B | $4.51B | $3.43B | $3.55B | $4.07B | $4.67B | |
| PP&E (Net) | $4.50B | $4.78B | $5.21B | $5.37B | $5.55B | $5.32B | $5.61B | $6.14B | $7.05B | $8.15B | |
| PP&E (Gross) | $8.91B | $9.16B | $9.51B | $9.64B | $9.76B | $9.35B | $9.65B | $10.30B | $11.50B | $12.42B | |
| Accum. Depreciation | $4.41B | $4.38B | $4.30B | $4.27B | $4.20B | $4.03B | $4.04B | $4.16B | $4.45B | $4.27B | |
| Goodwill | $3.32B | $3.79B | $3.96B | $4.17B | $4.22B | $4.22B | $4.33B | $4.56B | $4.72B | $6.52B | |
| Intangibles | $7M | $15M | $20M | $2M | · | · | · | · | $10M | $14M | |
| Other Non-current Assets | $2.10B | $2.17B | $2.05B | $2.01B | $1.91B | $1.90B | $2.21B | $1.54B | $1.54B | $2.59B | |
| Total Assets | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B | |
| Accounts Payable | $842M | $913M | $912M | $773M | $830M | $783M | $811M | $887M | $967M | $995M | |
| Accrued Liabilities | · | · | · | · | · | · | $1.13B | $1.09B | $1.13B | $1.23B | |
| Current Liabilities | $2.21B | $2.35B | $2.14B | $2.19B | $2.36B | $2.81B | $2.28B | $2.39B | $2.36B | $2.89B | |
| Capital Leases | $537M | $535M | $563M | $605M | $535M | $524M | $487M | $84M | $287M | $302M | |
| Deferred Tax | $25M | $231M | $369M | $354M | $192M | $29M | $200M | $26M | $19M | $411M | |
| Other Non-current Liabilities | $891M | $828M | $739M | $644M | $827M | $1.60B | $894M | $1.01B | $1.36B | $1.57B | |
| Total Liabilities | $14.04B | $15.37B | $15.28B | $15.40B | $16.03B | $17.06B | $17.25B | $16.82B | $17.61B | $19.66B | |
| Long-term Debt | $10.40B | $11.45B | $11.49B | $11.63B | $12.14B | $12.22B | $13.40B | $13.60B | $13.91B | $15.24B | |
| Total Debt | $10.38B | $11.43B | $11.47B | $11.61B | $12.11B | $12.09B | $13.38B | · | · | · | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Retained Earnings | $-3.57B | $-4.08B | $-3.56B | $-3.43B | $-3.48B | $-3.71B | $-4.22B | $-3.54B | $-2.76B | $-299M | |
| AOCI | $-9M | $-10M | $-14M | $-21M | $-14M | $-13M | $-9M | $-10M | $-21M | $-62M | |
| Stockholders' Equity | $-1.39B | $-1.91B | $-1.39B | $-1.37B | $-1.37B | $-1.62B | $-2.22B | $-1.53B | $-767M | $1.61B | |
| Liabilities + Equity | $13.20B | $14.05B | $14.46B | $14.67B | $15.22B | $16.01B | $15.61B | $15.86B | $17.45B | $21.94B | |
| Shares Outstanding | 138,626,917 | 138,919,641 | 136,774,911 | 134,703,717 | 132,146,282 | 129,612,117 | 117,822,631 | 116,248,376 | 114,651,004 | 113,876,580 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $426M | $486M | $505M | $534M | $540M | $558M | $608M | $700M | $861M | $1.10B | |
| Stock-based Comp | $11M | $17M | $22M | $20M | $25M | $13M | $10M | $13M | $24M | $46M | |
| Deferred Tax | $-243M | $-116M | $35M | $165M | $171M | $-187M | $203M | $-3M | $-454M | $-116M | |
| Restructuring | · | · | · | · | $3M | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | $239M | $352M | $2.80B | $1.83B | |
| Operating Cash Flow | $543M | $480M | $210M | $300M | $-131M | $2.18B | $385M | $274M | $773M | $1.14B | |
| CapEx | $335M | $360M | $467M | $415M | $469M | $440M | $438M | $527M | $564M | $744M | |
| Investing Cash Flow | $847M | $-275M | $-26M | $-259M | $-524M | $177M | $-2M | $-245M | $1.07B | $630M | |
| Net Debt Issued | $-6.52B | $-5.06B | $-4.32B | $-2.36B | $-4.43B | $-5.49B | $-3.56B | $-2.03B | $-5.39B | $-6.71B | |
| Financing Cash Flow | $-1.17B | $-206M | $-264M | $-430M | $-514M | $-895M | $-363M | $-396M | $-1.52B | $-1.71B | |
| Net Change in Cash | $223M | $-1M | $-80M | $-389M | $-1.17B | $1.46B | $20M | $-367M | $325M | $54M | |
| Taxes Paid | $249M | $171M | $91M | $-6M | $-4M | $-2M | $3M | $19M | $-4M | $16M | |
| Free Cash Flow | $208M | $120M | $-257M | $-115M | $-600M | $1.74B | $-53M | $-253M | $209M | $393M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% | 4.9% | 1.5% | · | · | |
| Net Margin | 4.1% | -4.1% | -1.1% | 0.38% | 1.9% | 4.3% | -5.1% | -5.6% | · | · | |
| Pretax Margin | 5.8% | -2.2% | 1.7% | 2.9% | 4.0% | 3.6% | -3.3% | -5.1% | · | · | |
| EBITDA Margin | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% | 9.6% | 9.5% | 6.4% | · | · | |
| ROA | 3.7% | -3.6% | -0.91% | 0.31% | 1.5% | 3.2% | -4.3% | -4.7% | -12.5% | -7.1% | |
| ROE | -30.8% | 31.2% | 9.6% | -3.4% | -15.3% | -26.6% | 36.0% | 68.5% | -580.0% | -61.1% | |
| ROIC | 15.5% | 7.3% | 0.73% | 4.1% | 9.6% | 15.5% | 8.0% | -13.3% | 206.0% | -50.0% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | 1.5 | 1.4 | 1.5 | 1.6 | 1.5 | 1.5 | 1.7 | 1.6 | |
| Quick Ratio | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 | 1.3 | 1.1 | 1.1 | 1.3 | 1.2 | |
| Debt / Equity | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 | -7.4 | -6.0 | · | · | · | |
| LT Debt / Equity | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 | -7.4 | -6.0 | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.9 | 0.9 | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | · | · | |
| Receivables Turnover | 5.7 | 5.6 | 5.8 | 6.0 | 6.2 | 5.6 | 5.7 | 6.0 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-10.06 | $-13.78 | $-10.18 | $-10.15 | $-10.38 | $-12.54 | $-18.82 | $-13.20 | $-6.69 | $14.18 | |
| Revenue / Share | $92.47 | $95.64 | $95.75 | $93.89 | $94.70 | $101.15 | $116.14 | $125.57 | · | · | |
| Cash Flow / Share | $4.02 | $3.63 | $1.61 | $2.31 | $-1.00 | $18.69 | $3.38 | $2.43 | $6.92 | $10.27 | |
| Cash / Share | $1.88 | $0.27 | $0.28 | $0.88 | $3.84 | $12.93 | $1.83 | $1.69 | $4.91 | $2.09 | |
| EPS (TTM) | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 | $4.39 | $-5.93 | $-6.99 | $-22.00 | $-15.54 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.2% | 1.1% | 2.3% | -1.3% | 4.9% | · | · | · | · | · | |
| Revenue CAGR 3Y | 0.74% | 0.71% | 1.9% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 1.1% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | · | · | · | -80.1% | -59.9% | · | · | · | · | · | |
| EPS CAGR 3Y | 120.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.0% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | · | · | · | -80.0% | -55.0% | · | · | · | · | · | |
| Net Income CAGR 3Y | 122.8% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.08% | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B | $11.79B | $13.21B | $14.15B | $15.35B | $18.44B | |
| Net Income TTM | $509M | $-516M | $-133M | $46M | $230M | $511M | $-675M | $-788M | $-2.46B | $-1.72B | |
| Market Cap | $433M | $415M | $428M | $582M | $1.76B | $963M | $342M | $328M | $488M | $637M | |
| Enterprise Value | $10.55B | $11.81B | $11.86B | $12.08B | $13.36B | $11.38B | $13.51B | · | · | · | |
| P/E | 0.8 | -0.8 | -3.1 | 12.3 | 7.6 | 1.7 | -0.5 | -0.4 | -0.2 | -0.4 | |
| P/S | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| P/B | -0.3 | -0.2 | -0.3 | -0.4 | -1.3 | -0.6 | -0.2 | -0.2 | -0.6 | 0.4 | |
| P / Cash Flow | 0.8 | 0.9 | 2.0 | 1.9 | -13.4 | 0.4 | 0.9 | 1.2 | 0.6 | 0.6 | |
| P / FCF | 2.1 | 3.5 | -1.7 | -5.1 | -2.9 | 0.6 | -6.4 | -1.3 | 2.3 | 1.6 | |
| EV / EBITDA | 7.1 | 21.8 | 12.4 | 14.7 | 9.5 | 10.1 | 10.7 | · | · | · | |
| EV / FCF | 50.7 | 98.4 | -46.1 | -105.0 | -22.3 | 6.5 | -254.9 | · | · | · | |
| EV / Revenue | 0.8 | 0.9 | 0.9 | 1.0 | 1.1 | 1.0 | 1.0 | · | · | · | |
| Earnings Yield | 120.8% | -130.4% | -32.6% | 8.1% | 13.2% | 59.1% | -204.5% | -247.9% | -516.4% | -278.0% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.83B | $2.96B | $3.11B | $3.09B | $3.13B | $3.16B | $3.26B | $3.09B | $3.14B | $3.14B | $3.18B | $3.09B | $3.12B | $3.11B | $3.14B | $3.02B | |
| Cost of Revenue | $401M | $441M | $446M | $460M | $469M | $489M | $507M | $469M | $483M | $487M | $493M | $489M | $504M | $507M | $497M | $492M | |
| Operating Expenses | $2.44B | $2.68B | $2.66B | $2.84B | $2.62B | $2.88B | $2.99B | $3.29B | $2.90B | $2.91B | $2.85B | $2.91B | $2.87B | $2.90B | $2.91B | $2.82B | |
| Operating Income | $389M | $281M | $449M | $243M | $512M | $284M | $278M | $-205M | $238M | $231M | $328M | $173M | $246M | $210M | $228M | $204M | |
| Interest Income | $1M | $1M | $0 | $1M | $1M | · | $1M | $1M | · | · | · | · | · | · | · | · | |
| Pretax Income | $180M | $64M | $221M | $-2M | $438M | $67M | $64M | $-419M | $50M | $22M | $194M | $-33M | $40M | $6M | $324M | $70M | |
| Income Tax | $76M | $89M | $61M | $-173M | $118M | $42M | $91M | $-64M | $24M | $28M | $108M | $19M | $38M | $26M | $-123M | $70M | |
| Net Income | $70M | $-58M | $110M | $130M | $282M | $-13M | $-71M | $-391M | $-13M | $-41M | $47M | $-91M | $-38M | $-51M | $415M | $-42M | |
| EPS (Basic) | $0.51 | $-0.43 | $0.83 | $0.97 | $2.11 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $0.36 | $-0.69 | $-0.29 | $-0.40 | $3.20 | $-0.32 | |
| EPS (Diluted) | $0.51 | $-0.43 | $0.82 | $0.96 | $2.09 | $-0.10 | $-0.53 | $-2.95 | $-0.10 | $-0.32 | $0.36 | $-0.69 | $-0.29 | $-0.40 | $3.20 | $-0.32 | |
| Shares (Basic) | 135,494,789 | 134,417,158 | · | 133,787,535 | 133,763,733 | 132,876,691 | · | 132,376,226 | 132,344,504 | 131,272,044 | · | 130,698,907 | 130,659,672 | 129,688,917 | · | 129,141,673 | |
| Shares (Diluted) | 136,505,102 | 134,417,158 | · | 135,187,592 | 134,882,981 | 132,876,691 | · | 132,376,226 | 132,344,504 | 131,272,044 | · | 130,698,907 | 130,659,672 | 129,688,917 | · | 129,141,673 | |
| EBITDA | $389M | $281M | · | $243M | $512M | $284M | · | $-205M | $238M | $231M | · | $173M | $246M | $210M | · | $204M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $149M | $712M | $260M | $123M | $456M | $431M | $37M | $33M | $39M | $48M | · | $91M | $118M | $144M | · | $300M | |
| Receivables | $2.14B | $2.14B | $2.08B | $2.16B | $2.26B | $2.33B | $2.29B | $2.04B | $2.19B | $2.19B | · | $2.16B | $2.04B | $2.04B | · | $1.97B | |
| Other Current Assets | $308M | $421M | $381M | $325M | $351M | $61M | $358M | $402M | $292M | $307M | · | $325M | $339M | $227M | · | $301M | |
| Current Assets | $3.08B | $3.77B | $3.23B | $3.20B | $3.66B | $3.41B | $3.30B | $3.11B | $3.20B | $3.17B | · | $3.25B | $3.19B | $3.11B | · | $3.27B | |
| PP&E (Net) | $4.18B | $4.20B | $4.50B | $4.62B | $4.66B | $4.74B | $4.78B | $4.96B | $5.22B | $5.22B | · | $5.16B | $5.25B | $5.25B | · | $5.45B | |
| PP&E (Gross) | $8.04B | $8.09B | $8.91B | $9.06B | $9.02B | $9.20B | $9.16B | $9.09B | $9.59B | $9.61B | · | $9.37B | $9.53B | $9.56B | · | $9.73B | |
| Accum. Depreciation | $3.86B | $3.89B | $4.41B | $4.44B | $4.37B | $4.46B | $4.38B | $4.13B | $4.37B | $4.39B | · | $4.21B | $4.28B | $4.30B | · | $4.28B | |
| Goodwill | $3.23B | $3.13B | $3.32B | $3.54B | $3.60B | $3.79B | $3.79B | $3.94B | $3.97B | $3.96B | $3.96B | $3.94B | $4.05B | $4.05B | $4.17B | $4.20B | |
| Intangibles | · | · | $7M | · | · | · | $15M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $1.65B | $2.05B | $2.10B | $1.81B | $1.71B | $1.94B | $2.17B | $1.86B | $1.99B | $2.04B | · | $2.27B | $2.10B | $2.15B | · | $1.94B | |
| Total Assets | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | · | $14.67B | $14.65B | $14.62B | · | $14.91B | |
| Accounts Payable | $713M | $790M | $842M | $894M | $970M | $974M | $913M | $842M | $896M | $941M | · | $837M | $736M | $712M | · | $820M | |
| Current Liabilities | $2.02B | $2.57B | $2.21B | $2.18B | $2.29B | $2.37B | $2.35B | $2.13B | $2.17B | $2.14B | · | $2.15B | $2.08B | $2.13B | · | $2.38B | |
| Capital Leases | $527M | $504M | $537M | $527M | $514M | $535M | $535M | $528M | $542M | $546M | · | $560M | $580M | $588M | · | $563M | |
| Deferred Tax | $25M | $25M | $25M | $30M | $240M | $205M | $231M | $239M | $351M | $354M | · | $344M | $362M | $351M | · | $477M | |
| Other Non-current Liabilities | $901M | $922M | $891M | $866M | $850M | $806M | $828M | $815M | $721M | $726M | · | $694M | $722M | $647M | · | $726M | |
| Total Liabilities | $13.02B | $14.14B | $14.04B | $14.19B | $14.74B | $15.22B | $15.37B | $15.18B | $15.29B | $15.29B | · | $15.57B | $15.47B | $15.41B | · | $16.09B | |
| Long-term Debt | · | · | $10.40B | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | $9.55B | $10.13B | · | $10.59B | $10.84B | $11.30B | · | $11.47B | $11.50B | $11.53B | · | $11.82B | $11.73B | $11.70B | · | $11.94B | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | · | $1M | $1M | $1M | · | $1M | |
| Retained Earnings | $-3.56B | $-3.63B | $-3.57B | $-3.68B | $-3.81B | $-4.09B | $-4.08B | $-4.01B | $-3.62B | $-3.60B | · | $-3.61B | $-3.52B | $-3.48B | · | $-3.85B | |
| AOCI | $-11M | $-10M | $-9M | $-5M | $-5M | $-7M | $-10M | $-8M | $-13M | $-16M | · | $-23M | $-19M | $-18M | $-21M | $-33M | |
| Stockholders' Equity | $-1.39B | $-1.45B | $-1.39B | $-1.50B | $-1.63B | $-1.92B | $-1.91B | $-1.82B | $-1.44B | $-1.43B | · | $-1.46B | $-1.49B | $-1.45B | · | $-1.79B | |
| Liabilities + Equity | $12.18B | $13.18B | $13.20B | $13.24B | $13.64B | $13.89B | $14.05B | $13.90B | $14.41B | $14.42B | · | $14.67B | $14.65B | $14.62B | · | $14.91B | |
| Shares Outstanding | 141,010,284 | 140,916,712 | 138,626,917 | 140,119,616 | 140,119,616 | 140,302,924 | 138,919,641 | 138,936,058 | 138,960,194 | 138,966,388 | · | 136,772,094 | 136,802,806 | 136,749,427 | · | 134,698,067 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $108M | $114M | $108M | $108M | $105M | $105M | $129M | $117M | $125M | $115M | $121M | $128M | $124M | $132M | $136M | $137M | |
| Stock-based Comp | $2M | $3M | $5M | $-1M | $3M | $4M | $5M | $4M | $2M | $6M | $6M | $6M | $4M | $6M | $6M | $6M | |
| Operating Cash Flow | $88M | $-297M | $266M | $69M | $88M | $120M | $216M | $67M | $101M | $96M | $90M | $29M | $86M | $5M | $9M | $137M | |
| CapEx | $76M | $76M | $94M | $65M | $91M | $85M | $109M | $70M | $88M | $93M | $110M | $130M | $105M | $122M | $131M | $93M | |
| Investing Cash Flow | $-23M | $1.02B | $142M | $-81M | $342M | $444M | $-143M | $75M | $-108M | $-99M | $180M | $-101M | $-86M | $-19M | $-52M | $30M | |
| Net Debt Issued | · | $-351M | · | · | · | $-1.09B | · | · | · | $-885M | · | · | · | $-757M | · | · | |
| Financing Cash Flow | $-628M | $-274M | $-271M | $-321M | $-405M | $-170M | $-69M | $-148M | $-2M | $13M | $-323M | $45M | $-26M | $40M | $-139M | $-213M | |
| Net Change in Cash | $-563M | $452M | $137M | $-333M | $25M | $394M | $4M | $-6M | $-9M | $10M | $-53M | · | · | $26M | $-182M | $-46M | |
| Taxes Paid | $61M | $0 | $441M | $-91M | $181M | $80M | $303M | $-48M | $-84M | $0 | $152M | $-24M | $-37M | · | $0 | $0 | |
| Free Cash Flow | · | $-373M | · | · | · | $35M | · | · | · | $3M | · | · | · | $-117M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 13.8% | 9.5% | · | 7.9% | 16.3% | 9.0% | · | -6.6% | 7.6% | 7.4% | · | 5.6% | 7.9% | 6.8% | · | 6.7% | |
| Net Margin | 2.5% | -2.0% | · | 4.2% | 9.0% | -0.41% | · | -12.7% | -0.41% | -1.3% | · | -2.9% | -1.2% | -1.6% | · | -1.4% | |
| Pretax Margin | 6.4% | 2.2% | · | -0.06% | 14.0% | 2.1% | · | -13.6% | 1.6% | 0.70% | · | -1.1% | 1.3% | 0.19% | · | 2.3% | |
| EBITDA Margin | 13.8% | 9.5% | · | 7.9% | 16.3% | 9.0% | · | -6.6% | 7.6% | 7.4% | · | 5.6% | 7.9% | 6.8% | · | 6.7% | |
| ROA | 0.54% | -0.43% | · | 0.96% | 2.0% | -0.09% | · | -2.7% | -0.09% | -0.28% | · | -0.62% | -0.26% | -0.34% | · | -0.27% | |
| ROE | -4.6% | 3.4% | · | -7.8% | -18.4% | 0.78% | · | 23.8% | 0.89% | 2.9% | · | 5.6% | 2.4% | 3.6% | · | 2.5% | |
| ROIC | 2.8% | -1.3% | · | -228.6% | 4.1% | 1.1% | · | -1.8% | 1.2% | -0.62% | · | 2.6% | 0.12% | -6.8% | · | 0.00% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.5 | · | 1.5 | 1.6 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.4 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.2 | 1.2 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | |
| Debt / Equity | -6.9 | -7.0 | · | -7.0 | -6.6 | -5.9 | · | -6.3 | -8.0 | -8.1 | · | -8.1 | -7.9 | -8.1 | · | -6.7 | |
| LT Debt / Equity | -6.9 | -7.0 | · | -7.0 | -6.6 | -5.9 | · | -6.3 | -8.0 | -8.1 | · | -8.1 | -7.9 | -8.1 | · | -6.7 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.3 | 1.3 | · | 1.5 | 1.4 | 1.4 | · | 1.5 | 1.5 | 1.5 | · | 1.5 | 1.5 | 1.5 | · | 1.5 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-9.86 | $-10.32 | · | $-10.72 | $-11.64 | $-13.71 | · | $-13.12 | $-10.37 | $-10.28 | · | $-10.70 | $-10.88 | $-10.57 | · | $-13.26 | |
| Revenue / Share | $20.70 | $22.06 | · | $22.83 | $23.23 | $23.77 | · | $23.34 | $23.73 | $23.92 | · | $23.61 | $23.84 | $23.96 | · | $23.42 | |
| Cash Flow / Share | · | $-2.21 | · | · | · | $0.90 | · | · | · | $0.73 | · | · | · | $0.04 | · | · | |
| Cash / Share | $1.06 | $5.05 | · | $0.88 | $3.25 | $3.07 | · | $0.24 | $0.28 | $0.35 | · | $0.67 | $0.86 | $1.05 | · | $2.23 | |
| EPS (TTM) | $1.86 | $3.44 | · | $2.42 | $-1.49 | $-3.68 | · | $-3.01 | $-0.75 | $-0.94 | · | $1.82 | $2.19 | $-0.04 | · | $-1.47 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $11.98B | $12.29B | · | $12.64B | $12.65B | $12.65B | · | $12.55B | $12.55B | $12.52B | · | $12.45B | $12.39B | $12.21B | · | $12.30B | |
| Net Income TTM | $252M | $464M | · | $328M | $-193M | $-488M | · | $-398M | $-98M | $-123M | · | $235M | $284M | $-4M | · | $-192M | |
| Market Cap | $471M | $414M | · | $450M | $476M | $379M | · | $843M | $467M | $486M | · | $397M | $602M | $670M | · | $290M | |
| Enterprise Value | $9.87B | $9.83B | · | $10.92B | $10.86B | $11.25B | · | $12.28B | $11.93B | $11.97B | · | $12.13B | $12.21B | $12.22B | · | $11.93B | |
| P/E | 1.8 | 0.9 | · | 1.3 | -2.3 | -0.7 | · | -2.0 | -4.5 | -3.7 | · | 1.6 | 2.0 | -122.5 | · | -1.5 | |
| P/S | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | |
| P/B | -0.3 | -0.3 | · | -0.3 | -0.3 | -0.2 | · | -0.5 | -0.3 | -0.3 | · | -0.3 | -0.4 | -0.5 | · | -0.2 | |
| P / Cash Flow | · | -1.4 | · | · | · | 3.2 | · | · | · | 5.1 | · | · | · | 134.0 | · | · | |
| EV / Revenue | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | 1.0 | 1.0 | · | 1.0 | |
| Earnings Yield | 55.7% | 117.0% | · | 75.4% | -43.8% | -136.3% | · | -49.6% | -22.3% | -26.9% | · | 62.8% | 49.8% | -0.82% | · | -68.4% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $12.48B | $12.63B | $12.49B | $12.21B | $12.37B |
| Betriebsgewinnmarge % | 11.9% | 4.3% | 7.7% | 6.7% | 11.3% |
| Nettoergebnis | $509M | $-516M | $-133M | $46M | $230M |
| Verwässerte EPS | $3.77 | $-3.90 | $-1.02 | $0.35 | $1.76 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | -7.4 | -6.0 | -8.2 | -8.5 | -8.8 |
| Liquiditätsgrad | 1.5 | 1.4 | 1.5 | 1.4 | 1.5 |
| Quick Ratio | 1.1 | 1.0 | 1.1 | 1.0 | 1.1 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $208M | $120M | $-257M | $-115M | $-600M |
Institutionelle Eigentümer (13F) 197 Einreicher · $415.1M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 31 (+9 vs. Vorquartal) | 24 (+4 vs. Vorquartal) | 69 (+6 vs. Vorquartal) | 54 (-9 vs. Vorquartal) | +7.0M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| CastleKnight Management LP | $44.704.517 | 13.384.586 | 10,77% | Aktien |
| Apollo Management Holdings, L.P. | $39.610.817 | 11.859.526 | 9,54% | Aktien |
| BlackRock, Inc. | $36.507.995 | 10.930.538 | 8,79% | Aktien |
| VANGUARD GROUP INC | $28.605.579 | 9.168.455 | 6,89% | Aktien |
| Eversept Partners, LP | $26.267.680 | 7.864.575 | 6,33% | Aktien |
| NOMURA HOLDINGS INC | $22.388.384 | 6.703.109 | 5,39% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $17.668.370 | 5.289.931 | 4,26% | Aktien |
| WHITEBOX ADVISORS LLC | $12.467.362 | 3.732.743 | 3,00% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $10.582.352 | 3.167.702 | 2,55% | Aktien |
| STATE STREET CORP | $10.226.622 | 3.061.863 | 2,46% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10.082.117 | 3.018.598 | 2,43% | Aktien |
| Saba Capital Management, L.P. | $9.626.444 | 2.882.169 | 2,32% | Aktien |
| Owl Creek Asset Management, L.P. | $8.452.277 | 2.530.622 | 2,04% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $8.176.380 | 2.448.018 | 1,97% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $7.854.253 | 2.351.460 | 1,89% | Aktien |
| D. E. Shaw & Co., Inc. | $7.829.388 | 2.344.128 | 1,89% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $7.651.362 | 2.290.827 | 1,84% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $7.365.822 | 2.205.336 | 1,77% | Aktien |
| Diameter Capital Partners LP | $6.138.793 | 1.837.962 | 1,48% | Aktien |
| BANK OF AMERICA CORP /DE/ | $5.903.847 | 1.767.619 | 1,42% | Aktien |
| GOLDMAN SACHS GROUP INC | $5.868.073 | 1.756.908 | 1,41% | Aktien |
| TWO SIGMA ADVISERS, LP | $5.816.476 | 1.864.255 | 1,40% | Aktien |
| CARRONADE CAPITAL MANAGEMENT, LP | $5.230.000 | 1.565.847 | 1,26% | Aktien |
| Allianz Asset Management GmbH | $5.167.919 | 1.547.281 | 1,24% | Aktien |
| MORGAN STANLEY | $4.800.489 | 1.437.272 | 1,16% | Aktien |
| NORTHERN TRUST CORP | $4.681.414 | 1.401.621 | 1,13% | Aktien |
| Silver Rock Financial LP | $3.674.000 | 1.100.000 | 0,89% | Aktien |
| CITADEL ADVISORS LLC | $3.475.360 | 1.040.527 | 0,84% | Aktien |
| Assenagon Asset Management S.A. | $2.788.275 | 834.813 | 0,67% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $2.642.231 | 791.087 | 0,64% | Aktien |
| Jefferies Financial Group Inc. | $2.481.286 | 742.900 | 0,60% | Aktien |
| Alta Fundamental Advisers LLC | $2.161.411 | 647.129 | 0,52% | Aktien |
| Bank of New York Mellon Corp | $2.122.084 | 635.354 | 0,51% | Aktien |
| MARSHALL WACE, LLP | $1.906.575 | 570.831 | 0,46% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.701.580 | 509.455 | 0,41% | Aktien |
| ExodusPoint Capital Management, LP | $1.664.603 | 498.384 | 0,40% | Aktien |
| READYSTATE ASSET MANAGEMENT LP | $1.657.729 | 496.326 | 0,40% | Aktien |
| WOLVERINE ASSET MANAGEMENT LLC | $1.339.674 | 401.100 | 0,32% | Kaufoption |
| Helix Partners Management LP | $1.336.000 | 400.000 | 0,32% | Aktien |
| Susquehanna Portfolio Strategies, LLC | $1.280.940 | 383.515 | 0,31% | Aktien |
| Voleon Capital Management LP | $1.247.032 | 373.363 | 0,30% | Aktien |
| Invesco Ltd. | $1.076.599 | 322.335 | 0,26% | Aktien |
| TUDOR INVESTMENT CORP ET AL | $999.388 | 299.218 | 0,24% | Aktien |
| Pathstone Holdings, LLC | $895.621 | 268.150 | 0,22% | Aktien |
| Prescott Group Capital Management, L.L.C. | $863.076 | 258.406 | 0,21% | Aktien |
| UBS Group AG | $851.089 | 254.817 | 0,21% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $835.000 | 250.000 | 0,20% | Verkaufsoption |
| FEDERATED HERMES, INC. | $812.599 | 243.293 | 0,20% | Aktien |
| LPL Financial LLC | $737.239 | 220.730 | 0,18% | Aktien |
| IEQ CAPITAL, LLC | $657.963 | 196.995 | 0,16% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Tianqiao Chen, Shanda Media Limited, Shanda Global Investment Limited, Shanda Global Capital Limited, Shanda Asset Management Holdings Limited ×10 Einreichungen | 11. März 2021 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 56 Insider · 29 Führungskräfte · 23 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Kevin J Hammons | CEO | 1. März 2026 A | 895.545 | 0 | 0 | $0 |
| Tim Hingtgen | CEO | 1. März 2025 A | 1.388.781 | 0 | 0 | $0 |
| Jason K Johnson | EVP & CFO | 1. März 2026 A | 268.439 | 0 | 0 | $0 |
| Thomas J Aaron | EVP and CFO | 7. Dezember 2019 F | 241.515 | 0 | 0 | $0 |
| Larry W Cash | President and CFO | 1. März 2017 A | 568.152 | 0 | 0 | $0 |
| Miguel S Benet | President and CMO | 1. März 2025 D | 47.635 | 0 | 0 | $0 |
| Austen D Mason | Regional President | 1. März 2025 A | 142.500 | 0 | 0 | $0 |
| Mark B Medley | Regional President | 1. März 2025 A | 128.637 | 0 | 0 | $0 |
| Chad A Campbell | Regional President | 1. März 2025 A | 136.815 | 0 | 0 | $0 |
| Charles J Cova | Regional President | 1. März 2024 A | 58.701 | 0 | 0 | $0 |
| Lynn T Simon | President and CMO | 1. März 2024 A | 482.657 | 0 | 0 | $0 |
| Beryl Ramsey | Division President | 1. März 2019 A | 62.969 | 0 | 0 | $0 |
| Patton Paul Smith | Division President | 1. März 2019 F | 119.017 | 0 | 0 | $0 |
| Iii John W Mcclellan | Division President | 1. März 2017 A | 41.242 | 0 | 0 | $0 |
| Robert O Horrar | Division President | 1. März 2017 A | 68.649 | 0 | 0 | $0 |
| Martin Bonick | Division President | 1. März 2017 A | 100.458 | 0 | 0 | $0 |
| Michael T Portacci | Division President | 1. März 2017 A | 110.156 | 0 | 0 | $0 |
| Thomas Daniel Miller | Division President | 1. März 2016 A | 112.107 | 0 | 0 | $0 |
| David Lewis Miller | President and COO | 1. März 2016 A | 440.840 | 0 | 0 | $0 |
| William S Hussey | Division President | 28. Oktober 2015 M | 121.568 | 0 | 0 | $0 |
| Martin Dewayne Smith | Division President | 3. Juni 2015 M | 94.111 | 0 | 0 | $0 |
| Gary D Newsome | Division President - Group Ops | 25. August 2008 M | 118.286 | 0 | 0 | $0 |
| David V. Rice | EVP-Clinical Operations & CMO | 1. Juni 2026 A | 30.000 | 0 | 0 | $0 |
| Phillip A. Posey | SVP & CAO | 1. März 2026 A | 51.736 | 0 | 0 | $0 |
| Justin D Pitt | Pres,Chief Legal&Admin Officer | 1. März 2026 A | 287.750 | 0 | 0 | $0 |
| Kevin A Stockton | EVP, Operations & Development | 1. März 2026 A | 208.290 | 0 | 0 | $0 |
| Rachel A Seifert | Executive VP and Secretary | 1. März 2017 F | 243.065 | 0 | 0 | $0 |
| Mark T Buford | SVP/Chief Accounting Officer | 25. Februar 2012 F | 78.379 | 0 | 0 | $0 |
| Martin G Schweinhart | Senior Vice President | 1. März 2006 A | 40.354 | 0 | 0 | $0 |
| William Norris Jennings | Direktor | 25. August 2026 S | 38.468 | 0 | 1 | $-118.400 |
| Ranga K Krishnan | Direktor | 30. Juni 2026 M | 170.023 | 0 | 0 | $0 |
| Fawn D Lopez | Direktor | 1. März 2026 A | · | 0 | 0 | $0 |
| Ronald L Burgess JR | Direktor | 1. März 2026 A | · | 0 | 0 | $0 |
| Susan W Brooks | Direktor | 1. März 2026 A | 108.695 | 0 | 0 | $0 |
| Hubert James Williams | Direktor | 1. März 2026 A | 211.863 | 0 | 0 | $0 |
| Joseph Arthur Hastings | Direktor | 1. März 2026 A | 0 | 0 | 0 | $0 |
| Elizabeth T Hirsch | Direktor | 1. März 2026 A | 162.059 | 0 | 0 | $0 |
| James S. Ely III | Direktor | 1. März 2026 A | 412.876 | 0 | 0 | $0 |
| John A Fry | Direktor | 1. März 2026 A | 268.966 | 0 | 0 | $0 |
| John A Clerico | Direktor | 1. März 2026 A | 368.763 | 0 | 0 | $0 |
| Michael Dinkins | Direktor | 1. März 2026 A | 225.882 | 0 | 0 | $0 |
| Wayne T Smith | Direktor | 1. März 2026 A | 5.217.579 | 0 | 0 | $0 |
| Julia B North | Direktor | 1. März 2021 A | 162.056 | 0 | 0 | $0 |
| Mitchell H Watson JR | Direktor | 16. Mai 2017 M | 22.594 | 0 | 0 | $0 |
| Harvey Klein MD | Direktor | 15. März 2010 M | 10.383 | 0 | 0 | $0 |
| Dale F Frey | Direktor | 31. März 2008 A | 20.000 | 0 | 0 | $0 |
| Thomas H Lister | Direktor | 21. September 2004 S | 0 | 0 | 0 | $0 |
| Thodore Forstmann | Direktor | 21. September 2004 S | 0 | 0 | 0 | $0 |
| Sandra Horbach | Direktor | 21. September 2004 S | 0 | 0 | 0 | $0 |
| Robert J Dole | Direktor | 6. Mai 2004 S | 0 | 0 | 0 | $0 |
| FLC XXIX PARTNERSHIP LP | 10%-Eigentümer | 21. September 2004 S | 0 | 0 | 0 | $0 |
| FLC XXX PARTNERSHIP LP | 10%-Eigentümer | 21. September 2004 S | 0 | 0 | 0 | $0 |
| Winston Hutchins | 10%-Eigentümer | 21. September 2004 S | 0 | 0 | 0 | $0 |
| FORSTMANN LITTLE & CO SUB DEBT & EQU MGMT BUYOUT PART VI LP | 10%-Eigentümer | 21. September 2004 S | 0 | 0 | 0 | $0 |
| FORSTMANN LITTLE & CO EQUITY PARTNERSHIP V L P | 10%-Eigentümer | 21. September 2004 S | 0 | 0 | 0 | $0 |
| Benjamin C Fordham | · | 1. März 2021 A | 254.608 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 25 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BSJR · Invesco Exchange-Traded Self-Indexe… | 2,68% | 23.297.000 | 1. Oktober 2026 | Täglich |
| EBIT · Harbor ETF Trust | 0,45% | 19.210 NS | 31. Juli 2026 | N-PORT |
| IWC · iShares Trust | 0,09% | 443.690 SH | 11. September 2026 | Täglich |
| IHF · iShares Trust | 0,05% | 223.947 SH | 11. September 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,03% | 113.109 SH | 19. August 2026 | Täglich |
| NEAR · iShares U.S. ETF Trust | 0,03% | 1.340.000 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 226.491 SH | 1. Oktober 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 3.425.206 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 62.038 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 746.733 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 349.881 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,01% | 289.348 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 202.789 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 33.838 NS | 31. Juli 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 203.848 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 42.177 SH | 3. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,00% | 6.184 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 31.135 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 1.347.195 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 3.813.888 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 9.817 SH | 19. August 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,00% | 24 NS | 31. Juli 2026 | N-PORT |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | · | · | 15. Juli 2026 | Täglich |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15. Juli 2026 | Täglich |
| IWN · iShares Trust | · | 1.223.127 SH | 11. September 2026 | Täglich |
CYH Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
12-Monats-Kursziel
8 Analysten · 2026-10-01Mittelwert-Ziel $3.16 +16,0%
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| CYH | $433M | 0.8 | -1.2% | 4.1% | -30.8% | · |
| SGRY | $2.00B | -25.3 | 6.2% | -2.4% | -4.5% | · |
| NUTX | $1.17B | 15.7 | 82.4% | 8.1% | 30.6% | 50.8% |
| ARDT | $1.26B | 9.2 | 6.0% | 2.1% | 11.2% | · |
| USPH | · | 55.0 | 16.3% | 5.1% | 8.2% | 19.2% |
| STLN | · | · | · | · | · | · |
| JYNT | $123M | 45.9 | 5.2% | 5.3% | 16.3% | · |
| HCA | $104.86B | 16.5 | 7.1% | 9.0% | -159.1% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.